TPG Gallery-The only authorized Shutterstock distributor in Taiwan

RNA vaccine, conceptual illustration. Close-up of human cells expressing viral proteins (red) after vaccination with an RNA (ribonucleic acid, blue helix) vaccine. The viral proteins will provoke an immune response, priming the body against infection with the actual virus. The first RNA vaccine approved for human use, developed against the SARS-CoV-2 coronavirus by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.

S
M
L
XL
Sketch

dpi

Details

Creative#:

TPG32175230

Source:

達志影像

Authorization Type:

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

N/A

Right to Privacy:

Same folder images:

Same folder images

Chinase Keywords
English Keywords

Account：
Password：
Confirm Password：
User Type：
Full Name：
Phone：
Email：
Company：
Latest Location：
Currency：
Language：
Postal Code：
Address：
Industry：

Account：

Password：

Confirm Password：

User Type：

Full Name：

Phone：

Email：

Company：

Latest Location：

Currency：

Language：

Postal Code：

Address：

Industry：

Subscribe to non-watermark images
Subscribe to Editorial Content
Subscribe E-Journal
Gender：
Fax：
Mobile Phone：
Department：
Title：
Country：
Province：
City：
Bank：
Sub-Branch：
Bank Account：

Subscribe to non-watermark images

Subscribe to Editorial Content

Subscribe E-Journal

Gender：

Fax：

Mobile Phone：

Department：

Title：

Country：

Province：

City：

Bank：

Sub-Branch：

Bank Account：

Details

Select your country or region

選擇您的語言